Long-term symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol

被引：0
|
作者：
Kane, JM
Swyzen, W
Wu, XL
McQuade, R
Esteinou, RG
Van Tran, Q
Marcus, R
Crandall, D
机构：
[1] Zucker Hillside Hosp, Glen Oaks, NY USA
[2] Bristol Myers Squibb Co, US Med Affairs, Plainsboro, NJ USA
[3] Bristol Myers Squibb Co, Biostat & Data Management, Wallingford, CT 06492 USA
[4] Otsuka Pharmaceut Co Ltd, Global Med Affairs, Princeton, NJ USA
[5] Bristol Myers Squibb Co, Global Med Affairs, Lawrenceville, NJ USA
[6] Otsuka Pharmaceut Co Ltd, US Med Affairs, Rockville, MD USA
[7] Bristol Myers Squibb Co, Pharmaceut Res Inst, Global Clin Res, Wallingford, CT 06492 USA
[8] Bristol Myers Squibb Co, Neurosci, Plainsboro, NJ USA
来源：
BIOLOGICAL PSYCHIATRY | 2006年 / 59卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
394
引用
收藏
页码：121S / 121S
页数：1
相关论文
共 50 条
  • [1] Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks
    Malhotra, A
    Kane, J
    Crandall, D
    Wu, XL
    Carson, W
    Oren, D
    Kostic, D
    Swyzen, W
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S199 - S200
  • [2] Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks
    Kane, John M.
    Crandall, David T.
    Marcus, Ronald N.
    Eudicone, James
    Pikalov, Amdrei, III
    Carson, William H.
    Swyzen, Wim
    SCHIZOPHRENIA RESEARCH, 2007, 95 (1-3) : 143 - 150
  • [3] Long-term symptomatic remission in patients with schizophrenia treated with aripiprazole or haloperidol: Results of a 52-week, double-blind, randomized study
    Kane, J. M.
    Swyzen, W.
    Wu, X.
    McQuade, R.
    Gutierrez-Esteinou, R.
    Tran, Q. -V
    Marcus, R. N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S275 - S276
  • [4] Long-term effects of aripiprazole and haloperidol on affective symptoms of schizophrenia
    Stock, E
    Archibald, DG
    Tourkodimitris, S
    Kujawa, M
    Marcus, R
    Carson, W
    Iwamoto, T
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 158 - 159
  • [5] Akathisia in schizophrenia patients treated with aripiprazole, haloperidol, or olanzapine - Analysis of three double-blind, long-term trials
    Loze, J.
    Talbott, S.
    Eudicone, J.
    McQuade, R. D.
    Buckley, P. F.
    EUROPEAN PSYCHIATRY, 2007, 22 : S122 - S122
  • [6] Long-term remission of schizophrenia in an adolescent treated with quetiapine
    Hayden, F
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2001, 11 (03) : 289 - 293
  • [7] Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia
    Nasrallah, Henry A.
    Aquila, Ralph
    Du, Yangchun
    Stanford, Arielle D.
    Claxton, Amy
    Weiden, Peter J.
    CNS SPECTRUMS, 2019, 24 (04) : 395 - 403
  • [8] Symptomatic remission in elderly schizophrenia patients treated with long-acting risperidone
    Tadger, Shelly
    Baruch, Yehuda
    Barak, Yoram
    INTERNATIONAL PSYCHOGERIATRICS, 2008, 20 (06) : 1245 - 1250
  • [9] Aripiprazole for long-term maintenance treatment of schizophrenia
    Van Peborgh, P
    McQuade, RD
    Carson, WH
    Saha, A
    Ingenito, GG
    Ali, M
    Archibald, DG
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) : A66 - A66
  • [10] Aripiprazole for long-term maintenance treatment of schizophrenia
    McQuade, RD
    Kujawa, M
    Saha, AR
    Ingenito, GG
    Ali, MW
    Luo, X
    Archibald, DG
    Carson, WH
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 295 - 295
12345